ORIGINAL RESEARCH
Published on 15 Jul 2026
Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changes
- 356 views
4,043
Total downloads
37k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
ORIGINAL RESEARCH
Published on 15 Jul 2026
ORIGINAL RESEARCH
Published on 15 Jul 2026
ORIGINAL RESEARCH
Published on 14 Jul 2026
SYSTEMATIC REVIEW
Published on 14 Jul 2026
REVIEW
Published on 13 Jul 2026
ORIGINAL RESEARCH
Published on 02 Jul 2026
ORIGINAL RESEARCH
Published on 26 Jun 2026
REVIEW
Published on 18 Jun 2026
ORIGINAL RESEARCH
Published on 12 Jun 2026
ORIGINAL RESEARCH
Published on 11 Jun 2026
ORIGINAL RESEARCH
Published on 02 Jun 2026
ORIGINAL RESEARCH
Published on 15 May 2026
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.